The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some serious risks. The agency asked the maker, Genzyme, to test the drug in more clinical trials. The drug was ...
Tags: FDA, Lemtrada, Genzyme, relapsing-remitting MS, rejection
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of ...
Tags: Genzyme, Biologics License Application, Lemtrada, multiple sclerosis
A vaccine normally used to thwart the respiratory illness tuberculosis also might help prevent the development of multiple sclerosis, a disease of the central nervous system, a new study suggests. In people who had a first episode of ...
The French maker of a drug used to treat multiple sclerosis is "extremely disappointed" it was rejected for U.S. sale, a corporate official said. David Meeker, president of Sanofi's Genzyme subsidiary, maker of the drug Lemtrada, said he ...
Genzyme, a Sanofi company, has obtained an approval from Health Canada for its Lemtrada (alemtuzumab) for the treatment of relapsing remitting multiple sclerosis (RRMS). Health Canada has approved Lemtrada for the management of adult ...
Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013. Currently both the firms are working on additional agreements for ...
Tags: Teva Licenses, Medicine
Aon Benfield, the global reinsurance intermediary and capital advisor of Aon plc (NYSE: AON), announces the appointment of Kelly Smith as President of its U.S. business, effective today. Kelly will report to Bryon Ehrhart, Chief Executive ...
Tags: Kelly Smith, Aon Benfield, President
As the temperature outside rises, cubical dwellers start to dream of pristine, sandy beaches and begin carefully plotting how many vacation days they can afford this year. Many others plan a last ditch effort to lose some weight before they ...
Tags: 3, health, boosting, summer-time, tip
For thousands of years, the human race has benefited significantly from the consumption of fresh coconut and its many derivatives. Coconut water, coconut flesh, and coconut oil all possess unique nutritional profiles that make them superior ...
You can prevent (and reverse) dementia, Alzheimer's disease, ALS, multiple sclerosis, plus many other neurodegenerative disorders by eating coconut-related foods. This is not just a "health nut" making these claims - it's all backed by ...
Tags: coconut oil, dementia, Alzheimer
Danish biotechnology firm Genmab has unveiled positive results from a Phase II study of its sclerosis drug candidate ofatumumab in relapsing-remitting multiple sclerosis (RRMS). In a randomized study of 232 patients with RRMS, treatment ...
Tags: Genmab, Sclerosis Drug
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...
AlterG, a US-based medical device company, has launched its AlterG Bionic Leg, a wearable, battery-powered, robotic mobility assistance device activated by a patient's intent to move. Designed for patients with impaired mobility, the ...
Tags: Wearable Bionic Leg
Coolture brings luxury cooling to the golf industry, where heat typically comes with the turf. National studies highlight the dangers of exertional heat-related injuries associated with golf. Unlike classic heat-related injuries, exertional ...
Tags: luxury cooling, golf industry